Bioventus Inc.
BVS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001665988
No open-market purchases or sales by Bioventus Inc. insiders were filed in the last 90 days; 156 institutions reported holding it in 13F filings for Q2 2026, worth $509.4M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Bioventus Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 98
- +29 vs. Q3 2021
- Shares held
- 31.2M
- +6.33M (+25.5%) vs. Q3 2021
- Total value
- $451.6M
- +$99.8M (+28.4%) vs. Q3 2021
- New holders
- 43
- 41 more added
- Sold out
- 14
- 9 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 156 | $509.4M |
| Q1 2026 | 157 | $466.4M |
| Q4 2025 | 148 | $373.3M |
| Q3 2025 | 135 | $328.9M |
| Q2 2025 | 134 | $320.3M |
| Q1 2025 | 144 | $427.0M |
| Q4 2024 | 151 | $477.8M |
| Q3 2024 | 138 | $537.1M |
| Q2 2024 | 103 | $222.2M |
| Q1 2024 | 84 | $178.0M |
| Q4 2023 | 80 | $175.4M |
| Q3 2023 | 67 | $108.9M |
| Q2 2023 | 66 | $92.6M |
| Q1 2023 | 71 | $33.4M |
| Q4 2022 | 85 | $81.9M |
| Q3 2022 | 94 | $245.9M |
| Q2 2022 | 98 | $232.0M |
| Q1 2022 | 105 | $447.0M |
| Q4 2021 | 98 | $451.6M |
| Q3 2021 | 69 | $351.8M |
| Q2 2021 | 53 | $364.5M |
| Q1 2021 | 45 | $334.2M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Bioventus Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −69,133−100.0% | Sold out |
| Pentwater Capital Management LP | 0 | $0 | 0.00% | −33,368−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −32,279−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −23,900−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −15,024−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −14,249−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −12,909−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −10,769−100.0% | Sold out |
| Sphinx Trading, LP | 0 | $0 | 0.00% | −601−100.0% | Sold out |
| Ellis Investment Partners, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −39−100.0% | Sold out |